4.5 Article

Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review

Bertrand Cariou et al.

Summary: This systematic literature review identified various evidence on nonalcoholic fatty liver disease (NAFLD) as a metabolic disorder, highlighting the complex interplay between NAFLD and metabolic dysfunction. Multidisciplinary collaboration and personalized treatment protocols are urgently needed to address the overall metabolic risk reduction and treatment for NAFLD/NASH patients.

DIABETES OBESITY & METABOLISM (2021)

Review Gastroenterology & Hepatology

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

Nahum Mendez-Sanchez et al.

Summary: The Latin American Association for the Study of the Liver aims to promote liver health and quality patient care, with a recent focus on fatty liver disease associated with metabolic dysfunction. A consensus was reached to rename the disease as metabolic-associated fatty liver disease and to diagnose it using a set of simple criteria. This change is expected to improve disease awareness and advancements in various aspects of the disease.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

Gamal Shiha et al.

Summary: Fatty liver disease associated with metabolic dysfunction is a global health problem, particularly prevalent in the Middle East and North Africa. The current nomenclature and diagnostic criteria for the disease have raised concerns among experts, leading to a proposal to rename it as metabolic-associated fatty liver disease (MAFLD) and diagnose it by positive criteria. Recommendations are being made to work with authorities in the region to implement these changes and improve healthcare for patients.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

Stefano Ciardullo et al.

Summary: Limited data are available on the epidemiological implications of renaming NAFLD to MAFLD. A cross-sectional study using NHANES data found similar prevalence rates of NAFLD and MAFLD in the general US population, with a high agreement between the two definitions and higher rates among Hispanic individuals. Additionally, patients with either NAFLD or MAFLD showed similar risk of advanced liver fibrosis.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

Mohammed Eslam et al.

Summary: The proposed framework for pediatric fatty liver diseases includes an age-appropriate MAFLD definition based on sex and age percentiles, recognizing the possibility of other coexisting systemic fatty liver diseases in children. This new MAFLD diagnostic criteria provide pediatricians with a conceptual scaffold for disease diagnosis, risk stratification, and improved clinical and multidisciplinary care, aligning with a definition that is valid across the lifespan.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Endocrinology & Metabolism

International Waist Circumference Percentile Cutoffs for Central Obesity in Children and Adolescents Aged 6 to 18 Years

Bo Xi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Gastroenterology & Hepatology

Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study

Kushala W. A. Abeysekera et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Comparison of MAFLD and NAFLD diagnostic criteria in real world

Su Lin et al.

LIVER INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease in Children

Jake P. Mann et al.

SEMINARS IN LIVER DISEASE (2018)

Review Pediatrics

Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter

Praveen Kumar Conjeevaram Selvakumar et al.

PEDIATRIC DRUGS (2018)

Article Endocrinology & Metabolism

Nonalcoholic fatty liver disease - A feature of the metabolic syndrome

G Marchesini et al.

DIABETES (2001)